Download PDF
CC BY-NC-ND 4.0 · Asian J Neurosurg 2020; 15(02): 382-384
DOI: 10.4103/ajns.AJNS_15_20
Case Report

Middle meningeal artery embolization following burr hole in chronic subdural hematoma

Abrar Arham
Department of Neurosurgery, National Brain Center, Jakarta
,
Nadya Zaragita
Department of Neurosurgery, National Brain Center, Jakarta
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Chronic subdural hematoma (CSDH) is a condition in which blood accumulates within the subdural space and may cause neurologic deficits. CSDH patients with neurologic deficits usually will undergo surgery, but reoccurrence is common. Middle meningeal artery (MMA) embolization has been proposed as one of the CSDH treatment options, either being used as a single treatment for the neurologically stable patients or certain conditions that may not allow patients to undergo surgery, or as a perioperative treatment. The authors reported a CSDH case with neurologic deficits who was on antiplatelet treatment that underwent both burr hole and MMA embolization for curation and prevention of rebleeding. The result showed near-complete blood resorption and no neurologic deficits.

Key-words:

Burr hole - chronic subdural hematoma - middle meningeal artery embolization - minimally invasive

Financial support and sponsorship

Nil.




Publication History

Received: 15 January 2020

Accepted: 11 March 2020

Article published online:
16 August 2022

© 2020. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Ban SP, Hwang G, Byoun HS, Kim T, Lee SU, Bang JS, et al. Middle meningeal artery embolization for chronic subdural hematoma. Radiology 2018;286:992-9.
  • 2 Link TW, Boddu S, Paine SM, Kamel H, Knopman J. Middle meningeal artery embolization for chronic subdural hematoma: A series of 60 cases. Neurosurgery 2019;85:801-7.
  • 3 Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KL, Hutchinson PJ. Pathophysiology of chronic subdural haematoma: Inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation 2017;14:108.
  • 4 Jiang R, Zhao S, Wang R, Feng H, Zhang J, Li X, et al. Safety and efficacy of atorvastatin for chronic subdural hematoma in Chinese patients: A randomized clinicaltrial. JAMA Neurol 2018;75:1338-46.
  • 5 Qiu S, Zhuo W, Sun C, Su Z, Yan A, Shen L. Effects of atorvastatin on chronic subdural hematoma: A systematic review. Medicine (Baltimore) 2017;96:e7290.
  • 6 Thavara BD, Kidangan GS, Rajagopalawarrier B. Comparative study of single burr-hole craniostomy versus twist-drill craniostomy in patients with chronic subdural hematoma. Asian J Neurosurg 2019;14:513-21.
  • 7 Jung YG, Jung NY, Kim E. Independent predictors for recurrence of chronic subdural hematoma. J Korean Neurosurg Soc 2015;57:266-70.
  • 8 Srivatsan A, Mohanty A, Nascimento FA, Hafeez MU, Srinivasan VM, Thomas A, et al. Middle meningeal artery embolization for chronic subdural hematoma: Meta-analysis and systematic review. World Neurosurg 2019;122:613-9.
  • 9 Kim E. Embolization therapy for refractory hemorrhage in patients with chronic subdural hematomas. World Neurosurg 2017;101:520-7.
  • 10 Fiorella D, Arthur AS. Middle meningeal artery embolization for the management of chronic subdural hematoma. J Neurointerv Surg 2019;11:912-5.